Price: $ 125 (Single User License) 
SynopsisICD Research’s “Cephalon, Inc.: Pharmaceuticals and Healthcare – Company Profile and SWOT Report” contains in depth information and data about the company and its operations. The profile contains a company overview, key facts,major products and services, swot analysis, business description, and company history.SummaryThis report is a crucial resource for industry executives and anyone looking to access key information about “Cephalon, Inc.”The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report.Scope- Examines and identifies key information and issues about “Cephalon, Inc.” for business intelligence requirements.- Studies and presents the company’s strengths, weaknesses, opportunities (growth potential) and threats (competition). Strategic and operational business information is objectively reported.- The profile also contains information on business operations, company history, major products and services, locations and subsidiaries.Reasons To Buy- Quickly enhance your understanding of “Cephalon, Inc.”- Gain insight into the marketplace and a better understanding of internal and external factors which could impact the industry.- Increase business/sales activities by understanding your competitors’ businesses better.- Recognize potential partnerships and suppliers.Key HighlightsCephalon, Inc. (Cephalon), is a biopharmaceutical company that specializes in the research, development and marketing of innovative therapeutic products. The company develops products for the treatment of cancer, pain, central nervous system (CNS), and inflammatory disease. Its product portfolio includes modafinil tablets, fentanyl buccal tablets, arsenic trioxide injections, tiagabine hydrochloride , modafinil , oral transmucosal fentanyl citrate and cyclobenzaprine hydrochloride extended release capsules. Cephalon has operations in the US, Europe, the Middle East and Africa and offers more than 150 branded and generic products in 100 countries. Cephalon is a subsidiary of Teva Pharmaceutical Industries Ltd. Cephalon is headquartered in Frazer, Pennsylvania, the US.
Original Post Cephalon, Inc.: Pharmaceuticals and Healthcare Company Profile, SWOT and Financial Report source Researchmoz Market Research
Company Profiles Reports
